| Name | Title | Contact Details |
|---|---|---|
Jeffrey Lui |
Chief Technology Officer | Profile |
Corey McCosh |
Director Information Security | Profile |
OCHN has a long-standing history of promoting independence, choice, and community inclusion for adults and children with intellectual / developmental disabilities, mental health concerns, and substance use disorders. Its mission to “inspire hope, empower people, and strengthen communities” reflects an unyielding belief in a "Valuable System for Valued People." Programs and supports provided by OCHN`s service network are available at www.oaklandchn.org. Most people who receive services through Oakland County`s public mental health system, which is managed by OCHN, have Medicaid insurance coverage.
Eniva Corporation is a Anoka, MN-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Health Care Medical Technologies, Inc. is a Sioux Falls, SD-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
NUCATS provides scientists with consultative resources and expertise in order to accelerate how quickly transformative scientific discoveries make their way to patients and the community. It is our goal to continually increase the quality, safety, efficiency and speed of innovative clinical and translational research.
MolecularMD founders Brian Druker (lead clinical investigator for Gleevec, the first molecularly-targeted anticancer agent) and Sheridan G. Snyder (entrepreneur, founder of Genzyme and Upstate Biotechnology) came together with the mission of providing precise, standardized molecular testing for new oncology drugs. The company’s initial accomplishment was in developing and implementing the only standardized assay for quantification of BCR-ABL expression levels, which proved critical to pharmaceutical sponsors in satisfying regulators for approval of the second-generation ABL kinase inhibitors nilotinib (Tasigna, Novartis) and dasatinib (Sprycel, BMS). With that foundational success in supporting pivotal international studies with centralized, high-quality diagnostic services, MolecularMD has become a preferred provider of molecular diagnostics products and services to pharmaceutical and biotech drug developers. Capabilities range from specialty molecular testing services performed in MolecularMD’s centralized CLIA-certified and CAP-accredited laboratory, to development of FDA approved companion diagnostics to support new drug registrations.